Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio
- Written by PR Newswire
- Duoning obtained exclusive license from BioAces for its cell analysis portfolio
- Through the partnership, the two companies will advance the development and commercialization of cell counters worldwide
SHANGHAI, Feb. 20, 2023 /PRNewswire/ -- Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") entered into a strategic partnership with BioAces...
Read more: Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio














